Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI).
David Cella, Susan Yount, Hongyan Du, Rahul Dhanda, Kathleen Gondek, Katie Langefeld, Jacquelyn George, William P. Bro, Celeste Kelly, Ronald M. Bukowski
PubMed, 2006
Abstract
This research paper explore the methodology and findings associated with PubMed. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).
- The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. 1993
- Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma 2007
- Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma 2007
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial 2010
- Development and Validation of a Scale to Measure Disease-Related Symptoms of Kidney Cancer 2007
- Measurement of health status 1989
- Symptom prevalence, characteristics and distress in a cancer population 1994
- Linking Clinical Relevance and Statistical significance in Evaluating Intra-Individual Changes in Health-Related Quality of Life 1999
- Symptom and quality of life survey of medical oncology patients at a Veterans Affairs medical center 2000
- Food and Drug Administration requirements for approval of new anticancer drugs. 1985